(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDSEQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDSEQ

ST13

US500000085494061

Class

42

Filing

85494061

Registration

4259050

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

03/31/2023

Trademark type

Word

Nice classes

42

Filing date

12/13/2011

Registration date

12/11/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/31/2023

Last transaction

03/31/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/08/2011

First use in commerce

12/08/2011

Drawing code

4

Owner type

03

Owner location

Boston, MA

Examiner

BLOHM, LINDA

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

The Brigham and Women's Hospital, Inc.

Representatives

Aaron Y. Silverstein Saunders & Silverstein LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical and scientific research in the field of using genomics in the clinical care of patients

Publications

History of USPTO decisions and trademark events.

37 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/31/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/31/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/31/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/30/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

09/19/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/27/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/27/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/27/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/27/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/27/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/11/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/04/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/04/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/04/2018

E815

TEAS SECTION 8 & 15 RECEIVED

07/26/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/26/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

12/11/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

12/11/2012

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/03/2012

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

11/02/2012

ALIE

ASSIGNED TO LIE

11/02/2012

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/30/2012

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/23/2012

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/23/2012

IUAF

USE AMENDMENT FILED

10/22/2012

EISU

TEAS STATEMENT OF USE RECEIVED

10/22/2012

DOCK

ASSIGNED TO EXAMINER

10/05/2012

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/17/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/22/2012

PUBO

PUBLISHED FOR OPPOSITION

05/22/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/02/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/11/2012

DOCK

ASSIGNED TO EXAMINER

04/03/2012

DOCK

ASSIGNED TO EXAMINER

03/22/2012

MPMK

NOTICE OF PSEUDO MARK MAILED

12/21/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/20/2011

NWAP

NEW APPLICATION ENTERED

12/16/2011

Continuous trademark protection

Get notified about every new filing that threatens MEDSEQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.